Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LOIS M BOOMS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1205260759
CMS profile
11137850
Location
PIGEON, MI

General Payments · PY2021–2024

$856.77

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$277.11

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.11 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $64.31 3
ABBVIE INC. $59.04 2
Astellas Pharma US Inc $46.58 3
Lilly USA, LLC $26.78 2
Axsome Therapeutics, Inc. $25.91 1
Bioventus LLC $22.25 1
GlaxoSmithKline, LLC. $17.06 1
Novo Nordisk AS $15.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $16.63 1
PY2022 $299.00 14
PY2023 $264.03 15
PY2024 $277.11 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.92 05/07/2024 Food and Beverage Undisputed 01/23/2026 1106797973 CMS
ABBVIE INC. $26.12 09/04/2024 Food and Beverage Undisputed 01/23/2026 1106797977 CMS
Astellas Pharma US Inc $15.49 09/03/2024 Food and Beverage Undisputed 01/23/2026 1139528088 CMS
Astellas Pharma US Inc $14.96 10/10/2024 Food and Beverage Undisputed 01/23/2026 1139537626 CMS
Astellas Pharma US Inc $16.13 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139549313 CMS
Axsome Therapeutics, Inc. $25.91 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148385940 CMS
Bioventus LLC $22.25 10/22/2024 Food and Beverage Undisputed 01/23/2026 1137452832 CMS
GlaxoSmithKline, LLC. $17.06 12/03/2024 Food and Beverage Undisputed 01/23/2026 1116557323 CMS
Lilly USA, LLC $13.16 06/05/2024 Food and Beverage Undisputed 01/23/2026 1135753537 CMS
Lilly USA, LLC $13.62 11/07/2024 Food and Beverage Undisputed 01/23/2026 1135768203 CMS
Novo Nordisk Inc $15.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 1100238864 CMS
Otsuka America Pharmaceutical, Inc. $19.61 01/30/2024 Food and Beverage Undisputed 01/23/2026 1119029854 CMS
Otsuka America Pharmaceutical, Inc. $20.58 05/27/2024 Food and Beverage Undisputed 01/23/2026 1119029856 CMS
Otsuka America Pharmaceutical, Inc. $24.12 10/07/2024 Food and Beverage Undisputed 01/23/2026 1119029858 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.